✦ LIBER ✦

Bevacizumab combination therapy in heavily pretreated, recurrent cervical cancer

✍ Scribed by Jason D. Wright; Dana Viviano; Matthew A. Powell; Randall K. Gibb; David G. Mutch; Perry W. Grigsby; Janet S. Rader

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bevacizumab plus cyclophosphamide in hea

✍ Justin C. Chura; Kelin Van Iseghem; Levi S. Downs Jr.; Linda F. Carson; Patricia 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 207 KB

Addition of bevacizumab to weekly paclit

✍ David M. O'Malley; Debra L. Richardson; Patrick S. Rheaume; Ritu Salani; Eric L. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 249 KB

Addition of bevacizumab to weekly paclit

✍ Maurie Markman 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Oxaliplatin/cisplatin (L-OHP/CDDP) combi

✍ P. Soulié; A. Bensmaíne; C. Garrino; P. Chollet; E. Brain; M. Fereres; C. Jasmin 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 905 KB

Salvage therapy with topotecan in heavil

✍ Lubomir Bodnar; Gabriel Wcislo; Anna Nasilowska; Katarzyna Szarlej-Wcislo; Agnie 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 314 KB

Combined oral cyclophosphamide and bevac

✍ José Miguel Jurado García; Alfonso Sánchez; Bella Pajares; Elisabeth Pérez; Lore 📂 Article 📅 2008 🏛 Springer Milan 🌐 Spanish ⚖ 189 KB